Read a report on a Phase 1 Clinical trial with a FAAH Inhibitor

A report on the causes of the accident during a Phase 1 clinical trial with a FAAH (Fatty Acid Amide Hydrolase) inhibitor BIA 10‐2474 in January 2016 is now available.  This report has been prepared by the Temporary Specialist Scientific Committee (TSSC) which was set up by the Director General of the Agence Nationale de Sécurité du Médicament et des produits de santé (ANSM), following the accident that occurred during the Phase 1, first‐in‐human clinical trial on the molecule, in Rennes on 10 January 2016.